The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Here’s what that means If the FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent ... Pfizer's says its COVID-19 ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

2.8 for Pfizer-BioNTech in SHIELD-Utah ... and intensity of reactogenicity symptoms from the protein-based COVID-19 vaccine observed in SHIELD-Utah add valuable insights to the public debate ...

A study published in January in the Annals of Internal Medicine, based on more than 144,000 children and co-authored by Morris, suggests that the Pfizer/BioNTech COVID-19 vaccine was effective in ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The Covid vaccines made by Pfizer and Moderna helped lift the world out of the pandemic, but a small group of people were left with debilitating side effects that they attribute to the vaccine.

Senior leaders at the US Food and Drug Administration began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for children last summer. The conversations gained ...

Pfizer's PFE non-COVID operational revenues improved in 2024 ... the United States can hurt Vyndaqel’s growth. Sales of key vaccine, Prevnar, are likely to have declined due to competitive ...